Neurobiology and Clinical Neuroscience
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section publishes reviews and original peer-reviewed papers of a high scientific level covering all aspects of the treatment of neurobiology and neurologic diseases. Topics include, but are not limited to neurogenesis, neuroplasticity, neuropharmacology, and neurotherapeutics, in vitro and in vivo responses to neurological diseases, identification of therapeutic targets, evaluation of diagnostic markers, and assessment of therapies for neurological disorders.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Oxidative Stress and Proteinopathy in Alzheimer's Disease (Deadline: 30 September 2024)
- Advancements in Neuroscience: A Special Issue in Honour of Ramón Y Cajal (Deadline: 30 September 2024)
- Neurotrauma: Mechanisms, Pathways, and Emerging Therapeutic Interventions (Deadline: 30 September 2024)
- Brain Injury: New Insights into Mechanisms and Future Promising Treatments (Deadline: 30 September 2024)
- Understanding Chronic Neurological Diseases: Pathophysiology, Biomarkers, and Therapeutic Approaches (Deadline: 30 September 2024)
- Recent Therapeutic Advances in Parkinson’s Disease (Deadline: 30 September 2024)
- Protein Misfolding and Functional Impairment in Neurodegenerative Diseases (Deadline: 30 September 2024)
- Alzheimer's Disease—115 Years after Its Discovery 2.0 (Deadline: 30 September 2024)
- Current Aspects on the Therapeutics of Aging, Cellular Senescence and Neurodegenerative Diseases (Deadline: 30 September 2024)
- Neurodevelopmental Disorders: From Pathophysiology to Novel Therapeutic Approaches—2nd Edition (Deadline: 30 September 2024)
- Glioblastoma: Pathogenetic, Diagnostic and Therapeutic Perspectives (Deadline: 30 September 2024)
- Advances in Molecular and Translational Research between Cognitive Function and Physical Activity (Deadline: 15 October 2024)
- Audiology and Vestibular System (Deadline: 31 October 2024)
- Neuroinflammation and Neuroprotection (Deadline: 31 October 2024)
- Neurodegenerative Diseases: Recent Advances and Future Perspectives—Volume II (Deadline: 31 October 2024)
- Molecular Research of Neurological and Psychiatric Disorders (Deadline: 31 October 2024)
- Biomarkers for Neurodegenerative Disorders: From Bench to Bedside (Deadline: 31 October 2024)
- The Role of Amyloids in Neurodegenerative Diseases: Current Insights and Future Perspectives (Deadline: 31 October 2024)
- The Interplay between miRNA and Mitochondrial Dysfunction in Neurodegenerative Disease (Deadline: 30 November 2024)
- Advanced Research in Neuroprotection (Deadline: 30 November 2024)
- Central Vestibular Disorders: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 30 November 2024)
- Biomarkers in Neurological Disorders (Deadline: 30 November 2024)
- Therapeutical Approaches in Brain Tumor Management and Neurosurgical Advancements (Deadline: 30 November 2024)
- Alzheimer's Disease Genetics (Deadline: 30 November 2024)
- Molecular Mechanisms and Therapy of Gliomas (Deadline: 30 November 2024)
- Dualistic Equilibrium in Neurotransmission and Beyond: Unraveling the Pathophysiology and Unlocking Novel Therapeutic Targets in Neuropsychiatric Disorders (Deadline: 30 November 2024)
- Advanced in Schizophrenia Research and Treatment (Deadline: 30 November 2024)
- Encephalitis and Viral Infection: Mechanisms and Therapies (Deadline: 30 November 2024)
- Animal Models of Neurological Disorders: Where Are We Now? (2nd Edition) (Deadline: 15 December 2024)
- Amyloid-β Dynamics and Neurodegeneration: Mechanistic Insights and Therapeutic Strategies (Deadline: 31 December 2024)
- Neurotransmitters in Health and Diseases (Deadline: 31 December 2024)
- Cellular and Molecular Biology of Neurodegenerative Disorders (Deadline: 31 December 2024)
- Neurodegenerative Diseases: From Mechanisms to Therapeutic Approaches (Deadline: 31 December 2024)
- Recent Advances in Craniofacial Pain and Headaches—Second Edition (Deadline: 31 December 2024)
- State of the Art: Prerequisites, Prevention and Treatment of Neurodegenerative Diseases (Deadline: 31 December 2024)
- Recent Advances in Understanding of the Role of Synuclein Family Members in Health and Disease: Third Edition (Deadline: 31 December 2024)
- Molecular Research of Neurodegenerative and Psychiatric Diseases, 2nd Edition (Deadline: 31 December 2024)
- Emerging Research in Neurorehabilitation (Deadline: 31 December 2024)
- Neurodegeneration in Cognitive Impairment and Mood Disorders for Experimental, Clinical, and Translational Neuropsychiatry—Second Edition (Deadline: 31 December 2024)
- Nanomedicine Applications in the Diagnosis and Treatment of Neurodegenerative Diseases (Deadline: 31 December 2024)
- Molecular Mechanisms and Novel Therapies for Brain Injury: 2nd Edition (Deadline: 31 December 2024)
- Emerging Challenges: Neurological Manifestations of Systemic Diseases and Medication-Induced Neurological Disorders (Deadline: 31 December 2024)
- Autonomic Dysfunction in Neurological Disorders: Novel Mechanisms and Targets (Deadline: 31 December 2024)
- Imaging and Neurochemical Biomarkers in Parkinsonian Disorders (Deadline: 31 December 2024)
- Long Noncoding RNAs in Brain Diseases (Deadline: 31 January 2025)
- State-of-the-Art Pain Medicine (Deadline: 31 January 2025)
- New Molecular Insights into the Pathogenesis and Drug Development of Neurodegenerative Diseases (Deadline: 31 January 2025)
- Traumatic CNS Injury: From Bench to Bedside (2nd Edition) (Deadline: 31 January 2025)
- Mitochondrial Dysfunction and Oxidative Stress (Deadline: 31 January 2025)
- Neuroinflammation: From Pathophysiologic Mechanisms to Therapeutic Strategies (Deadline: 31 January 2025)
- Mechanisms and Novel Therapeutic Approaches for Neurodegenerative Diseases (2nd Edition) (Deadline: 28 February 2025)
- Diagnosis and Treatment of Neurodegenerative Diseases in the Era of Precision Medicine (Deadline: 28 February 2025)
- Emerging Trends in Neurostimulation and Neuromodulation Research (Deadline: 28 February 2025)
- Advancements in Brain Diagnosis and Treatment: From Insights to Innovations (Deadline: 28 February 2025)
- Biomedical and Biochemical Basis of Neurodegenerative Diseases (Deadline: 28 February 2025)
- Cell Signaling and Molecular Regulation in Neurodegenerative Disease (Deadline: 28 February 2025)
- Molecular Characteristics of Cerebral Ischemia and Their Therapeutic Applications (Deadline: 28 February 2025)
- Inflammation and Peripheral Nervous System (Deadline: 28 February 2025)
- Diagnosis, Pathogenesis, Treatment and Prognosis of Glioblastoma (Deadline: 28 February 2025)
- Understanding Diseases Affecting the Central Nervous System (Deadline: 31 March 2025)
- Progress in Neurodevelopmental Disorders Research (Deadline: 31 March 2025)
- Neuropeptides, Dopamine and Their Interactions in Neuroscience (2nd Edition) (Deadline: 31 March 2025)
- Advances in Stroke Neuroprotection and Repair (Deadline: 31 March 2025)
- Mechanisms and Therapeutic Strategies of Brain and Spinal Cord Injury (Deadline: 30 June 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Feature Papers in Neuromodulation and Brain Stimulation
- Nervous System Inflammation
- Neurodegeneration No More: Cutting-Edge Technologies and Therapies in the Evolution of Neurodegenerative Disease Management
- Neurodevelopmental Disorders: From Pathophysiology to Treatment
- Neurogenic Neuroinflammation in Fibromyalgia
- Neurotoxicity: Mechanisms and Potential Therapeutic Strategies (Closed)
- Preclinical Breakthroughs to Clinical Frontiers: Translating Molecular Psychiatry
